In this study, we found that YKL-40 and c-Met immunohistochemical expression in pre-treatment rectal cancer biopsies reliably predicts a partial or lack of response to neoadjuvant CRT in patients with locally advanced rectal adenocarcinoma. This evidence concerns the gene MET and rectum adenocarcinoma.